IDH2 and glioblastoma: Sarac et al. reported significantly longer median OS in IDH-m glioblastomas (16.0 months; 95% CI: 11.41-20.58) compared with IDH-wt tumors (6.5 months; 95% CI: 0.0-15.35; p = 0.030).